Please login to the form below

Not currently logged in
Email:
Password:

e-Therapeutics appoints new CEO

Dr Raymond Barlow joins firm from Amgen

UK-based drug discovery and development firm e-Therapeutics appoints Dr Raymond Barlow as its new CEO.

Prior to e-Therapeutics, Barlow worked for a number of global pharma companies, including AstraZeneca as its director of corporate development and most recently at Amgen working on deals with Boehringer Ingelheim, GlaxoSmithKline and Geneta.

He said: “e-therapeutics is at the forefront of a new wave of science and has created a unique, computational-based drug discovery platform. This platform uses a range of truly cutting-edge technologies, including artificial intelligence.

“I am looking forward to engaging with our key stakeholders as well as subsequently positioning and promoting the company to an industry which needs the assets and solutions we can provide.”

10th April 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...

Infographics